{"id":3071,"date":"2026-04-10T08:29:01","date_gmt":"2026-04-10T05:29:01","guid":{"rendered":"https:\/\/merkezlaboratuvari.com\/test-listesi\/anti-mullerian-hormon-amh-2\/"},"modified":"2026-04-21T12:38:53","modified_gmt":"2026-04-21T09:38:53","slug":"anti-mullerian-hormon-amh","status":"publish","type":"page","link":"https:\/\/merkezlaboratuvari.com\/ar\/test-listesi\/anti-mullerian-hormon-amh\/","title":{"rendered":"Anti-M\u00fcllerian Hormon (AMH)"},"content":{"rendered":"<h1>Anti-M\u00fcllerian Hormon (AMH)<\/h1>\n<h2>Laboratuvar Bilgileri<\/h2>\n<ul>\n<li><strong>Yeni Kod:<\/strong> BIO8721<\/li>\n<li><strong>SUT Kodu:<\/strong> L100960<\/li>\n<li><strong>Eski Kod:<\/strong> HR0016<\/li>\n<li><strong>Kategori:<\/strong> \u0643\u064a\u0645\u064a\u0627\u0621 \u062d\u064a\u0648\u064a\u0629<\/li>\n<li><strong>Numune T\u00fcr\u00fc:<\/strong> Serum<\/li>\n<li><strong>Numune Kab\u0131:<\/strong> Sar\u0131 Kapak<\/li>\n<li><strong>\u00c7al\u0131\u015fma G\u00fcn\u00fc:<\/strong> Her g\u00fcn<\/li>\n<li><strong>\u00d6nemli Kriter:<\/strong> \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.<\/li>\n<li><strong>Raporlama Tarihi:<\/strong> Ayn\u0131 g\u00fcn 18:00<\/li>\n<\/ul>\n<h2>Anti-M\u00fcllerian Hormon (AMH) Testi Nedir?<\/h2>\n<p>Anti-M\u00fcllerian Hormon (AMH), laboratuvar ortam\u0131nda de\u011ferlendirilen bir biyokimya testidir. De\u011ferlendirme \u00e7o\u011fu zaman serum \u00f6rne\u011fi \u00fczerinden planlan\u0131r.<\/p>\n<ul>\n<li><strong>Tam Adi:<\/strong> Anti-M\u00fcllerian Hormon (M\u00fcllerian \u0130nhibiting Substance)<\/li>\n<li><strong>Kisaltmasi:<\/strong> AMH \/ MIS<\/li>\n<li><strong>Neyi \u00d6l\u00e7er:<\/strong> Kadinlarda overlerdeki k\u00fc\u00e7\u00fck antral ve preantral folik\u00fcllerden salgilanan AMH hormonunun kandaki d\u00fczeyini \u00f6l\u00e7er. AMH, over rezervinin (yumurta stoku) en g\u00fcvenilir g\u00f6stergelerinden biridir. Erkeklerde ise testislerdeki Sertoli h\u00fccrelerinden \u00fcretilir.<\/li>\n<\/ul>\n<p>Bu testin klinik anlam\u0131; istem nedeni, hastan\u0131n yak\u0131nmalar\u0131, ya\u015f\u0131, e\u015flik eden hastal\u0131klar\u0131, kullan\u0131lan y\u00f6ntem ve di\u011fer laboratuvar bulgular\u0131 ile birlikte de\u011ferlendirilir. Bu nedenle sonu\u00e7, tek ba\u015f\u0131na de\u011fil, b\u00fct\u00fcnc\u00fcl t\u0131bbi \u00e7er\u00e7eve i\u00e7inde yorumlanmal\u0131d\u0131r.<\/p>\n<h2>Anti-M\u00fcllerian Hormon (AMH) Hangi Durumlarda \u0130stenir?<\/h2>\n<p>Anti-M\u00fcllerian Hormon (AMH) testi, hekim taraf\u0131ndan klinik gereklilik g\u00f6r\u00fclen durumlarda istenebilir. \u0130stem gerek\u00e7esi hastan\u0131n mevcut tablosuna g\u00f6re de\u011fi\u015febilir.<\/p>\n<ul>\n<li><strong>Over rezervi degerlendirmesi<\/strong> (infertilite arastirmasi)<\/li>\n<li>IVF (t\u00fcp bebek) \u00f6ncesi over yanitinin \u00f6ng\u00f6r\u00fclmesi<\/li>\n<li>Erken menopoz \/ premat\u00fcr over yetmezligi (POI) s\u00fcphesi<\/li>\n<li>PKOS degerlendirmesi (AMH genellikle y\u00fcksek)<\/li>\n<li>Over gran\u00fcloza h\u00fccreli t\u00fcm\u00f6r takibi<\/li>\n<li>Erkeklerde: Kriptorsidizm (inmemis testis) degerlendirmesi, cinsiyet gelisim bozukluklari<\/li>\n<\/ul>\n<p>Ayn\u0131 test farkl\u0131 hastalarda farkl\u0131 klinik sorulara yan\u0131t aramak amac\u0131yla kullan\u0131labildi\u011fi i\u00e7in, nihai de\u011ferlendirme her zaman ki\u015fisel t\u0131bbi \u00f6yk\u00fc ve muayene bulgular\u0131 ile birlikte yap\u0131lmal\u0131d\u0131r.<\/p>\n<h2>Anti-M\u00fcllerian Hormon (AMH) Testi \u00d6ncesi Haz\u0131rl\u0131k<\/h2>\n<p>Haz\u0131rl\u0131k gereksinimi; testin t\u00fcr\u00fcne, numune yap\u0131s\u0131na ve laboratuvar\u0131n \u00e7al\u0131\u015fma kurallar\u0131na g\u00f6re de\u011fi\u015febilir. Test \u00f6ncesinde laboratuvar\u0131n ve hekimin verdi\u011fi talimatlar esas al\u0131nmal\u0131d\u0131r.<\/p>\n<ul>\n<li>A\u00e7lik genellikle gerekmez.<\/li>\n<li>AMH&#8217;nin en \u00f6nemli avantaji: <strong>menstr\u00fcel sikl\u00fcs\u00fcn herhangi bir g\u00fcn\u00fcnde<\/strong> alinabilir (sikl\u00fcs boyunca minimal dalgalanma g\u00f6sterir).<\/li>\n<li>Oral kontraseptif kullanimi AMH&#8217;yi hafif d\u00fcs\u00fcrebilir; hekim bilgilendirilmelidir.<\/li>\n<li>Hormonal tedaviler (GnRH agonistleri) AMH&#8217;yi gecici olarak baskilayabilir.<\/li>\n<\/ul>\n<p>Kullan\u0131lan ila\u00e7lar, takviyeler, yak\u0131n d\u00f6nemde ge\u00e7irilen hastal\u0131klar ve e\u015flik eden kronik durumlar sonucun yorumlanmas\u0131n\u0131 etkileyebilece\u011fi i\u00e7in sa\u011fl\u0131k profesyoneli ile payla\u015f\u0131lmal\u0131d\u0131r.<\/p>\n<h2>Anti-M\u00fcllerian Hormon (AMH) Testi Nas\u0131l Yap\u0131l\u0131r?<\/h2>\n<p>Anti-M\u00fcllerian Hormon (AMH) testi, uygun biyolojik \u00f6rnek al\u0131nd\u0131ktan sonra laboratuvar\u0131n belirledi\u011fi y\u00f6ntemle \u00e7al\u0131\u015f\u0131l\u0131r. Numunenin do\u011fru zamanda, uygun kapta ve uygun ta\u015f\u0131ma ko\u015fullar\u0131nda ula\u015ft\u0131r\u0131lmas\u0131 test kalitesi a\u00e7\u0131s\u0131ndan \u00f6nem ta\u015f\u0131r.<\/p>\n<ul>\n<li><strong>Numune T\u00fcr\u00fc:<\/strong> Serum<\/li>\n<li><strong>Numune Kab\u0131:<\/strong> Sar\u0131 Kapak<\/li>\n<li><strong>\u00c7al\u0131\u015fma G\u00fcn\u00fc:<\/strong> Her g\u00fcn<\/li>\n<li><strong>\u00d6nemli Kriter:<\/strong> \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.<\/li>\n<li><strong>Raporlama Tarihi:<\/strong> Ayn\u0131 g\u00fcn 18:00<\/li>\n<\/ul>\n<ul>\n<li><strong>Numune Tipi:<\/strong> Ven\u00f6z kan (serum)<\/li>\n<li><strong>Numune Alimi:<\/strong> Koldan standart kan alma islemiyle yaklasik 5 mL kan alinir.<\/li>\n<li><strong>Y\u00f6ntem:<\/strong> Imm\u00fcnoassay (kemil\u00fcminesans, ELISA)<\/li>\n<li><strong>Sonu\u00e7 S\u00fcresi:<\/strong> 1\u20133 is g\u00fcn\u00fc<\/li>\n<\/ul>\n<p>Baz\u0131 durumlarda \u00f6rnek kalitesi, numune miktar\u0131, ta\u015f\u0131ma s\u00fcresi veya teknik tekrar gereksinimi raporlama s\u00fcresini ve sonucun g\u00fcvenilirli\u011fini etkileyebilir.<\/p>\n<h2>Anti-M\u00fcllerian Hormon (AMH) Testi Ka\u00e7 G\u00fcnde \u00c7\u0131kar?<\/h2>\n<p>Mevcut laboratuvar bilgisine g\u00f6re bu test i\u00e7in raporlama s\u00fcresi: <strong>Ayn\u0131 g\u00fcn 18:00<\/strong> \u015feklindedir.<\/p>\n<p>Numunenin kabul zaman\u0131, laboratuvar\u0131n \u00e7al\u0131\u015fma plan\u0131, resmi tatiller veya gerekti\u011finde tekrar \u00e7al\u0131\u015fma gibi etkenler sonucu etkileyebilece\u011fi i\u00e7in en g\u00fcncel bilgi rapor tarihi \u00fczerinden de\u011ferlendirilmelidir.<\/p>\n<h2>Referans De\u011ferleri ve Sonu\u00e7lar\u0131n De\u011ferlendirilmesi<\/h2>\n<h3>Kadinlar (\u00fcreme \u00e7aginda)<\/h3>\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Deger<\/th><th>Yorum<\/th><\/tr><\/thead><tbody><tr><td>> 3,0 ng\/mL<\/td><td>Y\u00fcksek over rezervi (PKOS olabilir)<\/td><\/tr><tr><td>1,0 \u2013 3,0 ng\/mL<\/td><td>Normal over rezervi<\/td><\/tr><tr><td>0,5 \u2013 1,0 ng\/mL<\/td><td>Azalmis over rezervi<\/td><\/tr><tr><td>< 0,5 ng\/mL<\/td><td>Ciddi azalmis over rezervi \/ D\u00fcs\u00fck yanit beklenir<\/td><\/tr><tr><td>Saptanamaz<\/td><td>Menopoz veya premat\u00fcr over yetmezligi<\/td><\/tr><\/tbody><\/table><\/figure>\n\n<h3>Yasa G\u00f6re Beklenen AMH D\u00fczeyleri (yaklasik)<\/h3>\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Yas<\/th><th>Medyan Deger<\/th><\/tr><\/thead><tbody><tr><td>25 yas<\/td><td>3,0 \u2013 4,0 ng\/mL<\/td><\/tr><tr><td>30 yas<\/td><td>2,5 \u2013 3,5 ng\/mL<\/td><\/tr><tr><td>35 yas<\/td><td>1,5 \u2013 2,5 ng\/mL<\/td><\/tr><tr><td>40 yas<\/td><td>0,5 \u2013 1,5 ng\/mL<\/td><\/tr><tr><td>45 yas<\/td><td>< 0,5 ng\/mL<\/td><\/tr><\/tbody><\/table><\/figure>\n\n<h3>Erkekler<\/h3>\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Grup<\/th><th>Deger Araligi<\/th><\/tr><\/thead><tbody><tr><td>Yetiskin erkek<\/td><td>0,7 \u2013 19,0 ng\/mL<\/td><\/tr><\/tbody><\/table><\/figure>\n\n<p>> *Not: Referans degerleri laboratuvarlar ve kullanilan kitlere g\u00f6re degisebilir.*<\/p>\n<p>Referans bilgileri; kullan\u0131lan y\u00f6ntem, ya\u015f grubu, biyolojik \u00f6rnek tipi ve laboratuvar standard\u0131na g\u00f6re de\u011fi\u015febilece\u011finden, rapor \u00fczerinde yer alan laboratuvar yorumu esas al\u0131nmal\u0131d\u0131r.<\/p>\n<h2>Anti-M\u00fcllerian Hormon (AMH) Sonucu Nas\u0131l Yorumlan\u0131r?<\/h2>\n<p>Test sonucu tek ba\u015f\u0131na kesin tan\u0131 koydurmaz. Sonu\u00e7; klinik bulgular, di\u011fer laboratuvar verileri ve gerekli g\u00f6r\u00fcld\u00fc\u011f\u00fcnde ek incelemeler ile birlikte de\u011ferlendirilir.<\/p>\n<h3>AMH Y\u00fcksekligi<\/h3>\n<ul>\n<li><strong>PKOS<\/strong> (AMH genellikle > 4,5\u20135,0 ng\/mL; over antral folik\u00fcl sayisi artmistir)<\/li>\n<li>Over gran\u00fcloza h\u00fccreli t\u00fcm\u00f6r<\/li>\n<li>Over hiperstim\u00fclasyon riski (IVF&#8217;de)<\/li>\n<\/ul>\n<h3>AMH D\u00fcs\u00fckl\u00fcg\u00fc<\/h3>\n<ul>\n<li><strong>Azalmis over rezervi<\/strong> (dogal yasa bagli d\u00fcs\u00fcs)<\/li>\n<li><strong>Premat\u00fcr over yetmezligi (POI)<\/strong> (40 yasindan \u00f6nce menopoz)<\/li>\n<li>Over cerrahisi sonrasi (kistektomi, ooforektomi)<\/li>\n<li>Kemoterapi \/ radyoterapi sonrasi gonadotoksisite<\/li>\n<li>Endometrioma cerrahisi sonrasi<\/li>\n<li>Menopoz veya perimenopoz<\/li>\n<li>Sigara kullanimi (hafif d\u00fcs\u00fcs)<\/li>\n<\/ul>\n<p>\u00d6zellikle s\u0131n\u0131rda, d\u00fc\u015f\u00fck d\u00fczeyli veya beklenmeyen sonu\u00e7larda klinik korelasyon gerekir. Gerekti\u011finde tekrar test, panel de\u011ferlendirmesi veya ek laboratuvar incelemeleri planlanabilir.<\/p>\n<h2>Testin S\u0131n\u0131rl\u0131l\u0131klar\u0131<\/h2>\n<p>Her laboratuvar testinde oldu\u011fu gibi bu incelemenin de baz\u0131 s\u0131n\u0131rl\u0131l\u0131klar\u0131 vard\u0131r. Sonu\u00e7; \u00f6rnek kalitesi, \u00f6rnekleme zaman\u0131, ta\u015f\u0131ma ko\u015fullar\u0131 ve klinik ba\u011flamdan etkilenebilir.<\/p>\n<ul>\n<li>Tek bir laboratuvar sonucu, klinik \u00e7er\u00e7eve d\u0131\u015f\u0131nda eksik yorumlanabilir.<\/li>\n<li>Uygun olmayan numune kalitesi sonucun g\u00fcvenilirli\u011fini azaltabilir.<\/li>\n<li>Gerekti\u011finde ek testler olmadan tek ba\u015f\u0131na karar vermek yan\u0131lt\u0131c\u0131 olabilir.<\/li>\n<\/ul>\n<h2>Olas\u0131 Riskler<\/h2>\n<p>Risk \u00e7o\u011funlukla numune alma ve numune y\u00f6netimi s\u00fcreci ile ili\u015fkilidir. Testin kendisinden \u00e7ok, \u00f6rne\u011fin al\u0131nmas\u0131 ve uygun ko\u015fullarda \u00e7al\u0131\u015f\u0131lmas\u0131 \u00f6nem ta\u015f\u0131r.<\/p>\n<ul>\n<li>Kan alma islemi g\u00fcvenlidir; hafif agri, morarma olabilir.<\/li>\n<li>AMH&#8217;nin en b\u00fcy\u00fck avantaji <strong>sikl\u00fcsten bagimsiz<\/strong> olmasi; FSH ve E2&#8217;nin aksine herhangi bir g\u00fcn alinabilir.<\/li>\n<li>AMH, <strong>yumurta kalitesini degil, miktarini (kantitatif rezervi)<\/strong> yansitir; d\u00fcs\u00fck AMH bile kaliteli yumurta olusabilecegini dislamaz.<\/li>\n<li>AMH tek basina <strong>dogurganlik garantisi vermez ve kontrasepsiyon karari i\u00e7in kullanilmamalidir<\/strong>.<\/li>\n<li><strong>Yasa g\u00f6re<\/strong> degerlendirilmelidir; 35 yasinda 1,5 ng\/mL normal sinirda iken 25 yasinda d\u00fcs\u00fck kabul edilebilir.<\/li>\n<li>PKOS tanisinda AMH destekleyici bir belirte\u00e7tir ancak Rotterdam kriterleri \u00e7er\u00e7evesinde degerlendirilmelidir.<\/li>\n<li>Farkli kit ve y\u00f6ntemler arasi standardizasyon sorunlari vardir; ayni laboratuvarda takip \u00f6nerilir.<\/li>\n<li>Over cerrahisi (\u00f6zellikle endometrioma kistektomisi) AMH&#8217;yi kalici olarak d\u00fcs\u00fcrebilir.<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Anti-M\u00fcllerian Hormon (AMH) Laboratuvar Bilgileri Yeni Kod: BIO8721 SUT Kodu: L100960 Eski Kod: HR0016 Kategori: Biyokimya Numune T\u00fcr\u00fc: Serum Numune Kab\u0131: Sar\u0131 Kapak \u00c7al\u0131\u015fma G\u00fcn\u00fc: Her g\u00fcn \u00d6nemli Kriter: \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r. Raporlama Tarihi: Ayn\u0131 g\u00fcn 18:00 Anti-M\u00fcllerian Hormon (AMH) Testi Nedir? Anti-M\u00fcllerian Hormon (AMH), laboratuvar [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"parent":5,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"test_category":"Biyokimya","test_kodu":"BIO8721","numune_turu":"Serum","numune_kabi":"Sar\u0131 Kapak","calisma_gunu":"Her g\u00fcn","onemli_kriter":"\u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.","raporlama_tarihi":"Ayn\u0131 g\u00fcn 18:00","numune_red_kriterleri":"","aktarim_kodu":"","loinc_kodu":"","sut_kodu":"L100960","akredite":"","numune_miktari":"","alternatif_ornek":"","numune_alinma_sekli":"","stabilite_ozellikleri":"","calisma_yontemi":"","test_bilgisi":"","footnotes":""},"class_list":["post-3071","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/3071","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/types\/page"}],"replies":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/comments?post=3071"}],"version-history":[{"count":4,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/3071\/revisions"}],"predecessor-version":[{"id":9051,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/3071\/revisions\/9051"}],"up":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/5"}],"wp:attachment":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/media?parent=3071"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}